The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Blood glucose fluctuation 19
SANDOSTATIN LAR DEPOT Blood potassium decreased 19
SANDOSTATIN LAR DEPOT Hypothyroidism 19
SANDOSTATIN LAR DEPOT Incorrect product storage 19
SANDOSTATIN LAR DEPOT Mass 19
SANDOSTATIN LAR DEPOT Movement disorder 19
SANDOSTATIN LAR DEPOT Psoriasis 19
SANDOSTATIN LAR DEPOT Renal disorder 19
SANDOSTATIN LAR DEPOT Thyroid disorder 19
SANDOSTATIN Back pain 18
SANDOSTATIN LAR DEPOT Atrial fibrillation 18
SANDOSTATIN LAR DEPOT Blood cholesterol increased 18
SANDOSTATIN LAR DEPOT Blood chromogranin A increased 18
SANDOSTATIN LAR DEPOT Gastrointestinal neoplasm 18
SANDOSTATIN LAR DEPOT Hypersensitivity 18
SANDOSTATIN LAR DEPOT Jaundice 18
SANDOSTATIN LAR DEPOT Lung neoplasm 18
SANDOSTATIN LAR DEPOT Metastases to lung 18
SANDOSTATIN LAR DEPOT Metastases to oesophagus 18
SANDOSTATIN LAR DEPOT Productive cough 18

Total Records: 2,045     Number of Pages: 103